{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T23:44:21Z","timestamp":1769298261323,"version":"3.49.0"},"reference-count":69,"publisher":"Informa UK Limited","issue":"11","funder":[{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["2N41660"],"award-info":[{"award-number":["2N41660"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Council of Science & Technology (NST) grant by the Korea government","award":["CRC-15-04-KIST"],"award-info":[{"award-number":["CRC-15-04-KIST"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.1080\/13543776.2016.1230605","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T19:20:48Z","timestamp":1473276048000},"page":"1353-1366","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010 \u2013 2015; part 2)"],"prefix":"10.1080","volume":"26","author":[{"given":"TaeHun","family":"Kim","sequence":"first","affiliation":[{"name":"Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, Seoul, Republic of Korea"},{"name":"Biological Chemistry, Korea University of Science and Technology, Daejon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae Nim","family":"Pae","sequence":"additional","affiliation":[{"name":"Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, Seoul, Republic of Korea"},{"name":"Biological Chemistry, Korea University of Science and Technology, Daejon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"issue":"1","key":"CIT0001","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-3565(25)39521-2","volume":"267","author":"Romeo E","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.12.084"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.12.6390"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.123000"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.079459"},{"key":"CIT0006","unstructured":"Trigg WJ, Jones PA. S-enantiomer of tetracyclic indole derivative as pbr ligands. WO2015040151 A1. 2015."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1021\/jm00072a010"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(98)00374-6"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1021\/jm8003224"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1021\/jm030973k"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00689"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2004.04.025"},{"key":"CIT0013","unstructured":"Arstad E, Wilson I, Luthra SK, et al. Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr). WO 2007057705A1. 2007."},{"key":"CIT0014","unstructured":"Wadsworth HJ, Shan B, O\u2019shea D, et al. Imaging neuroinflammation. WO2010037851 A2. 2010."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.02.057"},{"key":"CIT0016","unstructured":"Jones PA. In vivo imaging method of mood disorders. US20130177501 A1. 2013."},{"key":"CIT0017","unstructured":"Wadsworth HJ, O\u2019shea D, Passmore J, et al. Indole derivatives. WO2010109007 A2. 2010."},{"key":"CIT0018","unstructured":"Morrison MS, Morisson-Iveson V, Trigg WJ. Macrophage imaging. WO2015040087 A1. 2015."},{"key":"CIT0019","unstructured":"Jones PA. In vivo imaging method for cancer. WO2012041953 A1. 2012."},{"key":"CIT0020","unstructured":"Achanath R, Balaji S, Fairway SM, et al. Tricyclic indole derivatives as pbr ligands. EP255289 A1. 2013."},{"key":"CIT0021","unstructured":"Trigg WJ, Jones PA. Carbazole compounds for in vivo imaging. WO2015040148 A1. 2015."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.052068"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.09.079"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(03)00083-X"},{"key":"CIT0025","unstructured":"Benavides J, Evanno Y, Ferzaz B, et al. Use of pyridazino[4,5-b]indole-1-acetamide deravatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepine receptors. WO2000044384 A1. 2000."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1628-5"},{"key":"CIT0027","unstructured":"Benavides J, Boutin H, Castel MN, et al. Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels. US20120039816 A1. 2012."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.07.091"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.07.033"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120473"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1398507"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2011.02166.x"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1002\/j.1532-2149.2013.00367.x"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/hup.757"},{"key":"CIT0035","unstructured":"Rajan ST, Rao GVP, inventors; Msn Laboratories Limited, India. assignee. Process for the preparation of etifoxine hydrochloride. patent IN2012CH03232 A. 2014."},{"key":"CIT0036","unstructured":"Putman D, Hogenkamp D, Dasse O, et al. Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use. US8110569 B2. 2012."},{"key":"CIT0037","unstructured":"Verleye M, Guern MEL, Girard P, et al. Neuroprotective compounds and pharmaceutical compositions comprising them. US8338410 B2. 2012."},{"key":"CIT0038","unstructured":"Verleye M, Girard P, Le GME. Treatment of degenerations and light-induced damage to the retina. WO2015113991 A1. 2015."},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914414107"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1017\/S1740925X12000129"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2014.02.045"},{"key":"CIT0042","unstructured":"Owen D, Wilkins M. Methods to predict binding affinity of tspo imaging agents to tspo. US20140301947 A1. 2014."},{"issue":"3","key":"CIT0043","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.neuroimage.2011.02.020","volume":"56","author":"Gulyas B","year":"2011","journal-title":"NeuroImage"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.2174\/1874471011205010019"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2009.00078.x"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.2174\/092986709788803150"},{"key":"CIT0047","unstructured":"\u00c9les J, Borza I, Tihanyi K, et al. A new diaza-benzofluoranthene derivative as drug. WO2013076646 A1. 2013."},{"key":"CIT0048","unstructured":"Katsumata S, Mitsui K, inventors; Ono Pharmaceutical Co., Ltd., Japan. assignee. Drug and method for preventing\/treating stress-induced diseases. patent WO2015190568 A1. 2015."},{"key":"CIT0049","unstructured":"Ohmoto K, Kato M, Kagamiishi Y, et al. Tricyclic compound and use thereof. WO2006068164 A1. 2006."},{"issue":"8","key":"CIT0050","first-page":"568","volume":"13","author":"Martin LJ","year":"2010","journal-title":"IDrugs"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.02.013"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22593"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.11.006"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.167486"},{"key":"CIT0055","unstructured":"Pruss R, Drouot C. Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants. US8338488 B2. 2012."},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-38"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu331"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1159\/000342981"},{"issue":"3","key":"CIT0059","doi-asserted-by":"crossref","first-page":"e00144","DOI":"10.1002\/prp2.144","volume":"3","author":"Schaller S","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00755"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.203216"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2012.08.019"},{"key":"CIT0063","unstructured":"Akula N, Greeson J, Lecanu L, et al. Structure based drug design of steroidogenesis inhibitors. WO2007103162 A2. 2007."},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.03.023"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2012.10.018"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.1.4.2820823"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2256"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1534"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2011.02.012"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2016.1230605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:13:55Z","timestamp":1749575635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2016.1230605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11,1]]}},"alternative-id":["10.1080\/13543776.2016.1230605"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2016.1230605","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}